Cargando…

Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol

OBJECTIVE: The objective was to compare the practical aspects of providing medication abortions through telemedicine and in-person clinic visits so that clinics can use this information when planning to add this service. STUDY DESIGN: We conducted a comparative retrospective chart review comparing t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiebe, Ellen R, Campbell, Mackenzie, Ramasamy, Harani, Kelly, Michaela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286176/ https://www.ncbi.nlm.nih.gov/pubmed/32550538 http://dx.doi.org/10.1016/j.conx.2020.100023

Ejemplares similares

Implementing medical abortion with mifepristone and misoprostol in Norway 1998–2013
por: Løkeland, Mette, et al.
Publicado: (2017)

Medical abortion with mifepristone and home administration of misoprostol up to 63 days’ gestation
por: Løkeland, Mette, et al.
Publicado: (2014)

Early medical abortion with self‐administered low‐dose mifepristone in combination with misoprostol
por: Song, Li‐Ping, et al.
Publicado: (2018)

Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: Zhao, Xiaoying, et al.
Publicado: (2021)

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
por: Shimels, Tariku, et al.
Publicado: (2023)

Retracted: Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone–misoprostol for medical abortion
por: Chinery, Lester, et al.
Publicado: (2020)

A Retrospective Cost-Effectiveness Analysis of Mifepristone–Misoprostol Medical Abortions in the First Year at the Regina General Hospital
por: Hunter, Caitlin, et al.
Publicado: (2021)

Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy
por: Shah, Deepa, et al.
Publicado: (2018)

Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location
por: Goldberg, Alisa B., et al.
Publicado: (2022)

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss
por: Hamel, Charlotte C., et al.
Publicado: (2022)

Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review
por: Abubeker, Ferid A., et al.
Publicado: (2020)

Medication Abortion Safety and Effectiveness With Misoprostol Alone
por: Jayaweera, Ruvani, et al.
Publicado: (2023)

Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial
por: Hamel, Charlotte, et al.
Publicado: (2021)

Dutch GPs’ views on prescribing mifepristone and misoprostol: a mixed-methods study
por: Schellekens, Julia EAP, et al.
Publicado: (2022)

Factors Influencing the Duration of Termination of Pregnancy for Fetal Anomaly with Mifepristone in Combination with Misoprostol
por: Reischer, Theresa, et al.
Publicado: (2023)

The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States
por: Mark, Alice, et al.
Publicado: (2021)

Oral toxicity of isotretinoin, misoprostol, methotrexate, mifepristone and levonorgestrel as pregnancy category X medications in female mice
por: KIM, SEONG-KWAN, et al.
Publicado: (2015)

Role of Combination OF Mifepristone and Misoprostol Verses Misoprostol alone in Induction of Labour in Late Intrauterin Fetal Death: A Prospective Study
por: Panda, Subrat, et al.
Publicado: (2013)

Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion < 63 days’ gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial
por: Dragoman, Monica V., et al.
Publicado: (2016)

Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial
por: Chu, Justin J, et al.
Publicado: (2020)

Dispensing mifepristone for medical abortion in Canada: Pharmacists’ experiences of the first year
por: Zusman, Enav Z., et al.
Publicado: (2023)

Mifepristone Antagonization with Progesterone to Avert Medication Abortion: A Scoping Review
por: DeBeasi, Paul L. C.
Publicado: (2023)

Mifepristone-misoprostol combination treatment for early pregnancy loss after embryo transfer: a case series
por: Esposito, Leah, et al.
Publicado: (2023)

Pharmacist checklist and resource guide for mifepristone medical abortion: User-centred development and testing
por: Rebic, Nevena, et al.
Publicado: (2021)

Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists
por: Zusman, Enav Z, et al.
Publicado: (2022)

The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2017)

Forensic Toxicological Aspects of Misoprostol Use in Pharmacological Abortions
por: Szpot, Paweł, et al.
Publicado: (2022)

Comparison of two doses and two routes of administration of misoprostol after pre-treatment with mifepristone for early pregnancy termination
por: von Hertzen, Helena, et al.
Publicado: (2008)

Subsequent placenta accreta after previous mifepristone-induced abortion: A case report
por: Zhao, Peng, et al.
Publicado: (2021)

Bleeding pattern after medical management of early pregnancy loss with mifepristone–misoprostol and its prognostic value: a prospective observational cohort study
por: Enzelsberger, Simon-Hermann, et al.
Publicado: (2021)

Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis
por: Wu, Hang-lin, et al.
Publicado: (2017)

Misoprostol in the era of COVID-19: a love letter to the original medical abortion pill
por: Jayaweera, Ruvani T., et al.
Publicado: (2020)

Effectiveness and acceptability of home use of misoprostol for medical abortion up to 10 weeks of pregnancy
por: Podolskyi, Volodymyr, et al.
Publicado: (2023)

Prevalence, attitudes and knowledge of misoprostol for self-induction of abortion in women presenting for abortion at Midwestern reproductive health clinics
por: Kerestes, Courtney, et al.
Publicado: (2019)

Telemedicine for medical abortion: a systematic review
por: Endler, M, et al.
Publicado: (2019)

Intravaginal Isoniazid (INH) and Sublingual Misoprostol Versus Sublingual Misoprostol Alone for First-Trimester Induced Abortion: A Randomized Controlled Trial
por: Haghighi, Ladan, et al.
Publicado: (2023)

In the name of public health: misoprostol and the new criminalization of abortion in Brazil
por: Assis, Mariana Prandini, et al.
Publicado: (2021)

Clinical Outcomes and Women’s Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa
por: Constant, Deborah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f2l96l7rqavbludr1ltnv09luo